Klinikum Sindelfingen-Böblingen; Frauenklinik
Boblingen, Germany
Women's health clinic in Böblingen, Baden-Württemberg
Bunsenstraße 120, 71032 Böblingen
About Klinikum Sindelfingen-Böblingen; Frauenklinik
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Clinical Trials at Klinikum Sindelfingen-Böblingen; Frauenklinik
During the past decade, Klinikum Sindelfingen-Böblingen; Frauenklinik conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
2013-04-03
2025-04-03
Active, not recruiting
1,487
A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2014-06-25
2018-05-29
Completed
444
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Sindelfingen-Böblingen; Frauenklinik"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Klinikum Sindelfingen-Böblingen; Frauenklinik
According to Clinical.Site data, the most researched conditions in "Klinikum Sindelfingen-Böblingen; Frauenklinik" are
"Breast Cancer" (2 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Klinikum Sindelfingen-Böblingen; Frauenklinik" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Sindelfingen-Böblingen; Frauenklinik
Most popular intervention types in "Klinikum Sindelfingen-Böblingen; Frauenklinik" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Docetaxel" (2 trials), "Pertuzumab" (2 trials), "Trastuzumab" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Sindelfingen-Böblingen; Frauenklinik
The vast majority of trials in "Klinikum Sindelfingen-Böblingen; Frauenklinik" are
3 trials for "All" genders.
Clinical Trials Status at Klinikum Sindelfingen-Böblingen; Frauenklinik
Currently, there are NaN active trials in "Klinikum Sindelfingen-Böblingen; Frauenklinik".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Klinikum Sindelfingen-Böblingen; Frauenklinik,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Sindelfingen-Böblingen; Frauenklinik, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".